Document Type : Review Article

Authors

1 Medical Laboratory Sciences.Faculty of Allied Health Sciences, Kuwait University. Kuwait.

2 School of Paramedical Sciences, Iran University of Medical Sciences, Tehran, Iran

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease of unknown etiology that results in progressive joint destruction and ultimately to disability. Currently effective biologic therapies, exist for approximately  40% of patients, but disease activity remains inadequately controlled in others. Therefore, it is crucial  to identify specific markers that predict therapeutic response in various patients, prior to the initiation of therapy.  DNA methylation , as a epigenetic factor, is increasingly being explored as a potential theranostic biomarker. It has been suggested that DNA methylation might contribute to RA development, nonetheless , with conflicting results. Epigenetic modules have provided a possible interface through which genetic and environmental risk factors  contribute to the susceptibility and pathogenesis of RA. Hence,  epigenetic regulators may provide promising drug targets to develop novel therapeutic drugs for tailored treatment of RA patients. Here we review the current knowledge regarding the role of DNA methylation in RA and indicate its potential therapeutic implications.

Keywords

1.McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. New England Journal of Medicine. 2011 Dec 8;365(23):2205-19.
2.Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. The Lancet. 2017 Jun 10;389(10086):2338-48.
3.Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19, 163–196 (2001).
4.Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. Jama. 2018 Oct 2;320(13):1360-72.
5.McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. The Lancet. 2017 Jun 10;389(10086):2328-37.
6.Okada Y, Eyre S, Suzuki A, Kochi Y, Yamamoto K. Genetics of rheumatoid arthritis: 2018 status. Annals of the rheumatic diseases. 2019 Apr 1;78(4):446-53.
7.Ai R, Laragione T, Hammaker D, Boyle DL, Wildberg A, Maeshima K, Palescandolo E, Krishna V, Pocalyko D, Whitaker JW, Bai Y. Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes. Nature communications. 2018 May 15;9(1):1-1.
8.Tseng CC, Lin YZ, Lin CH, Li RN, Tsai WC, Ou TT, Wu CC, Sung WY, Yen JH. Genetic and epigenetic alteration of the programmed cell death 1 in rheumatoid arthritis. European Journal of Clinical Investigation. 2019 Oct;49(10):e13094.
9.Meng H, Cao Y, Qin J, Song X, Zhang Q, Shi Y, Cao L. DNA methylation, its mediators and genome integrity. International journal of biological sciences. 2015;11(5):604.
10.Mazzone R, Zwergel C, Artico M, Taurone S, Ralli M, Greco A, Mai A. The emerging role of epigenetics in human autoimmune disorders. Clinical epigenetics. 2019 Dec;11(1):1-5.
11.Qiu H, Wu H, Chan V, Lau CS, Lu Q. Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity. Autoimmunity. 2017 Feb 17;50(2):71-81.
12.Bullock J, Rizvi SA, Saleh AM, Ahmed SS, Do DP, Ansari RA, Ahmed J. Rheumatoid arthritis: a brief overview of the treatment. Medical Principles and Practice. 2018;27(6):501-7.
13.Tam LS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis. Nature Reviews Rheumatology. 2010 Jul;6(7):399-405.
14.Glant TT, Mikecz K, Rauch TA. Epigenetics in the pathogenesis of rheumatoid arthritis. BMC medicine. 2014 Dec;12(1):1-5.
15.Ospelt C. Epigenetic biomarkers in rheumatology-the future?. Swiss Medical Weekly. 2016;146:w14312.
16.Hardy RS, Hülso C, Liu Y, Gasparini SJ, Fong-Yee C, Tu J, Stoner S, Stewart PM, Raza K, Cooper MS, Seibel MJ. Characterisation of fibroblast-like synoviocytes from a murine model of joint inflammation. Arthritis Research & Therapy. 2013 Feb;15(1):1-5.
17.Lefevre S, Meier FM, Neumann E, Muller-Ladner U. Role of synovial fibroblasts in rheumatoid arthritis. Current pharmaceutical design. 2015 Jan 1;21(2):130-41.
18.Nasonov EL, Lila AM. Rheumatoid arthritis: achievements and unresolved issues. Terapevticheskii arkhiv. 2019 May 15;91(5):4-7.
19.Hitchon CA, El-Gabalawy HS. Suppl 1: the synovium in rheumatoid arthritis. The open rheumatology journal. 2011;5:107.
20.Laria A, Lurati A, Marrazza M, Mazzocchi D, Re KA, Scarpellini M. The macrophages in rheumatic diseases. Journal of inflammation research. 2016;9:1.
21.Ciechomska M, Wilson CL, Floudas A, Hui W, Rowan AD, van Eden W, Robinson JH, Knight AM. Antigen‐specific B lymphocytes acquire proteoglycan aggrecan from cartilage extracellular matrix resulting in antigen presentation and CD 4+ T‐cell activation. Immunology. 2014 Jan;141(1):70-8.
22.Bogdanos DP, Smyk DS, Rigopoulou EI, Mytilinaiou MG, Heneghan MA, Selmi C, Gershwin ME. Twin studies in autoimmune disease: genetics, gender and environment. Journal of autoimmunity. 2012 May 1;38(2-3):J156-69.
23.Shi J, van Steenbergen HW, van Nies JA, Levarht EN, Huizinga TW, van der Helm-van AH, Toes RE, Trouw LA. The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis. Arthritis research & therapy. 2015 Dec;17(1):1-6.
24.Ciechomska M, O’Reilly S. Epigenetic modulation as a therapeutic prospect for treatment of autoimmune rheumatic diseases. Mediators of inflammation. 2016 Aug 10;2016.
25.Carmona-Rivera C, Carlucci PM, Moore E, Lingampalli N, Uchtenhagen H, James E, Liu Y, Bicker KL, Wahamaa H, Hoffmann V, Catrina AI. Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Science immunology. 2017 Apr 14;2(10):eaag3358.
26.Klein K, Kabala PA, Grabiec AM, Gay RE, Kolling C, Lin LL, Gay S, Tak PP, Prinjha RK, Ospelt C, Reedquist KA. The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts. Annals of the rheumatic diseases. 2016 Feb 1;75(2):422-9.
27.Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S. Strategies toward rheumatoid arthritis therapy; the old and the new. Journal of cellular physiology. 2019 Jul;234(7):10018-31.
28.Frisell T, Saevarsdottir S, Askling J. Family history of rheumatoid arthritis: an old concept with new developments. Nature Reviews Rheumatology. 2016 Jun;12(6):335-43.
29.Conigliaro P, D’Antonio A, Pinto S, Chimenti MS, Triggianese P, Rotondi M, Perricone R. Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay. Autoimmunity Reviews. 2020 Jun 1;19(6):102529.
30.van der Woude D, van der Helm-van AH. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 2018 Apr 1;32(2):174-87.
31.van der Woude D, van der Helm-van AH. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 2018 Apr 1;32(2):174-87.
32.Suzuki A, Kochi Y, Okada Y, Yamamoto K. Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis. FEBS letters. 2011 Dec 1;585(23):3627-32.
33.Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. Periodontitis in RA—the citrullinated enolase connection. Nature Reviews Rheumatology. 2010 Dec;6(12):727-30.
34.Singh JA, Saag KG, Bridges Jr SL, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, Curtis JR. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis & rheumatology. 2016 Jan;68(1):1-26.
35.Scott DL. Biologics‐based therapy for the treatment of rheumatoid arthritis. Clinical Pharmacology & Therapeutics. 2012 Jan;91(1):30-43.
36.Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. The Lancet. 2017 Jun 10;389(10086):2338-48.
37.McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. The Lancet. 2017 Jun 10;389(10086):2328-37.
38.Bullock J, Rizvi SA, Saleh AM, Ahmed SS, Do DP, Ansari RA, Ahmed J. Rheumatoid arthritis: a brief overview of the treatment. Medical Principles and Practice. 2018;27(6):501-7.
39.Oliver J, Plant D, Webster AP, Barton A. Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis. Biomarkers in Medicine. 2015 Jun;9(6):499-512.
40.Rein P, Mueller RB. Treatment with biologicals in rheumatoid arthritis: an overview. Rheumatology and therapy. 2017 Dec;4(2):247-61.
41.Zampeli E, Vlachoyiannopoulos PG, Tzioufas AG. Treatment of rheumatoid arthritis: unraveling the conundrum. Journal of autoimmunity. 2015 Dec 1;65:1-8.
42.Taylor PC, Abdul Azeez M, Kiriakidis S. Filgotinib for the treatment of rheumatoid arthritis. Expert Opinion on Investigational Drugs. 2017 Oct 3;26(10):1181-7.
43.Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JW, Burmester GR, de Wit M, Falzon L. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Annals of the rheumatic diseases. 2020 Jun 1;79(6):744-59.
44.Stricker SH, Köferle A, Beck S. From profiles to function in epigenomics. Nature Reviews Genetics. 2017 Jan;18(1):51-66.
45.Marchal C, Miotto B. Emerging concept in DNA methylation: role of transcription factors in shaping DNA methylation patterns. Journal of cellular physiology. 2015 Apr;230(4):743-51.
46.Nair N, Wilson AG, Barton A. DNA methylation as a marker of response in rheumatoid arthritis. Pharmacogenomics. 2017 Sep;18(14):1323-32.
47.Renauer P, Coit P, Jeffries MA, Merrill JT, McCune WJ, Maksimowicz-McKinnon K, Sawalha AH. DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus. Lupus science & medicine. 2015 Sep 1;2(1):e000101.
48.Blanch M, Mosquera JL, Ansoleaga B, Ferrer I, Barrachina M. Altered mitochondrial DNA methylation pattern in Alzheimer disease–related pathology and in Parkinson disease. The American journal of pathology. 2016 Feb 1;186(2):385-97.
49.Ouchi K, Takahashi S, Yamada Y, Tsuji S, Tatsuno K, Takahashi H, Takahashi N, Takahashi M, Shimodaira H, Aburatani H, Ishioka C. DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer. Cancer science. 2015 Dec;106(12):1722-9.
50.Nervi C, De Marinis E, Codacci-Pisanelli G. Epigenetic treatment of solid tumours: a review of clinical trials. Clinical epigenetics. 2015 Dec;7(1):1-20.
51.Cribbs A, Feldmann M, Oppermann U. Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications. Therapeutic advances in musculoskeletal disease. 2015 Oct;7(5):206-19.
52.Jin Z, Liu Y. DNA methylation in human diseases. Genes & diseases. 2018 Mar 1;5(1):1-8.
53.Sun B, Hu L, Luo ZY, Chen XP, Zhou HH, Zhang W. DNA methylation perspectives in the pathogenesis of autoimmune diseases. Clinical Immunology. 2016 Mar 1;164:21-7.
54.de Andres MC, Perez-Pampin E, Calaza M, Santaclara FJ, Ortea I, Gomez-Reino JJ, Gonzalez A. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate. Arthritis research & therapy. 2015 Dec;17(1):1-9.
55.Ishida K, Kobayashi T, Ito S, Komatsu Y, Yokoyama T, Okada M, Abe A, Murasawa A, Yoshie H. Interleukin‐6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. Journal of periodontology. 2012 Jul;83(7):917-25.
56.Park SH, Kim SK, Choe JY, Moon Y, An S, Park MJ, Kim DS. Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis. Molecules and cells. 2013 Apr;35(4):298-304.
57.Hammaker D, Whitaker JW, Maeshima K, Boyle DL, Ekwall AK, Wang W, Firestein GS. LBH gene transcription regulation by the interplay of an enhancer risk allele and DNA methylation in rheumatoid arthritis. Arthritis & rheumatology. 2016 Nov;68(11):2637-45.
58.Guderud K, Sunde LH, Flåm ST, Mæhlen MT, Mjaavatten MD, Lillegraven S, Aga AB, Evenrød IM, Norli ES, Andreassen BK, Franzenburg S. Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4+ Memory Than in CD4+ Naïve T Cells. Frontiers in immunology. 2020:194.
59.Guo S, Zhu Q, Jiang T, Wang R, Shen Y, Zhu X, Wang Y, Bai F, Ding Q, Zhou X, Chen G. Genome-wide DNA methylation patterns in CD4+ T cells from Chinese Han patients with rheumatoid arthritis. Modern rheumatology. 2017 May 4;27(3):441-7.
60.Sellars M, Huh JR, Day K, Issuree PD, Galan C, Gobeil S, Absher D, Green MR, Littman DR. Regulation of DNA methylation dictates Cd4 expression during the development of helper and cytotoxic T cell lineages. Nature immunology. 2015 Jul;16(7):746-54.
61.Viatte S, Plant D, Han B, Fu B, Yarwood A, Thomson W, Symmons DP, Worthington J, Young A, Hyrich KL, Morgan AW. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. Jama. 2015 Apr 28;313(16):1645-56.
62.Viatte S, Plant D, Bowes J, Lunt M, Eyre S, Barton A, Worthington J. Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. Annals of the rheumatic diseases. 2012 Dec 1;71(12):1984-90.
63.Viatte S, Massey J, Bowes J, Duffus K, arcOGEN Consortium, Eyre S, Barton A, Worthington J, Loughlin J, Arden N, Birrell F. Replication of associations of genetic loci outside the hla region with susceptibility to anti–cyclic citrullinated peptide–negative rheumatoid arthritis. Arthritis & rheumatology. 2016 Jul;68(7):1603-13.
64.Han GG, Lee JY, Jin GD, Park J, Choi YH, Kang SK, Chae BJ, Kim EB, Choi YJ. Tracing of the fecal microbiota of commercial pigs at five growth stages from birth to shipment. Scientific reports. 2018 Apr 16;8(1):1-9.
65.Lange CP, Campan M, Hinoue T, Schmitz RF, van der Meulen-de Jong AE, Slingerland H, Kok PJ, van Dijk CM, Weisenberger DJ, Shen H, Tollenaar RA. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PloS one. 2012 Nov 28;7(11):e50266.
66.Nair N, Wilson AG, Barton A. DNA methylation as a marker of response in rheumatoid arthritis. Pharmacogenomics. 2017 Sep;18(14):1323-32.
67.Plant D, Webster A, Nair N, Oliver J, Smith SL, Eyre S, Hyrich KL, Wilson AG, Morgan AW, Isaacs JD, Worthington J. Differential methylation as a biomarker of response to etanercept in patients with rheumatoid arthritis. Arthritis & Rheumatology. 2016 Jun;68(6):1353-60.
68.Maeshima K, Stanford SM, Hammaker D, Sacchetti C, Zeng LF, Ai R, Zhang V, Boyle DL, Muench GR, Feng GS, Whitaker JW. Abnormal PTPN11 enhancer methylation promotes rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and joint inflammation. JCI insight. 2016 May 19;1(7).
69.Svendsen AJ, Gervin K, Lyle R, Christiansen L, Kyvik K, Junker P, Nielsen C, Houen G, Tan Q. Differentially methylated DNA regions in monozygotic twin pairs discordant for rheumatoid arthritis: an epigenome-wide study. Frontiers in immunology. 2016 Nov 17;7:510.
70.Karouzakis E, Raza K, Kolling C, Buckley CD, Gay S, Filer A, Ospelt C. Analysis of early changes in DNA methylation in synovial fibroblasts of RA patients before diagnosis. Scientific reports. 2018 May 9;8(1):1-6.
71.Svendsen AJ, Gervin K, Lyle R, Christiansen L, Kyvik K, Junker P, Nielsen C, Houen G, Tan Q. Differentially methylated DNA regions in monozygotic twin pairs discordant for rheumatoid arthritis: an epigenome-wide study. Frontiers in immunology. 2016 Nov 17;7:510.
72.Tabares P, Berr S, Langenhorst D, Sawitzki B, Ten Berge I, Tony HP, Hünig T. Short‐term cytokine stimulation reveals regulatory T cells with down‐regulated Foxp3 expression in human peripheral blood. European journal of immunology. 2018 Feb;48(2):366-79.
73.Moosavi A, Ardekani AM. Role of epigenetics in biology and human diseases. Iranian biomedical journal. 2016 Nov;20(5):246.
74.Availableonline:https://www.epigenomics.com/wpcontent/uploads/2016/06/approval_pm_eng.pdf (accessed on 22 August 2016).
75.Nair N, Plant D, Verstappen SM, Isaacs JD, Morgan AW, Hyrich KL, Barton A, Wilson AG, MATURA investigators. Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis. Rheumatology. 2020 Jun 1;59(6):1364-71.